Curis | CRIS - Operating Expenses

Stock Price
1.02
Daily Change
-0.01 -0.97%
Monthly
-0.97%
Yearly
-65.66%
Q1 Forecast
1.11

Curis reported $-13.99M in Operating Expenses for its fiscal quarter ending in June of 2025.





Operating Expenses Change Date
Alaunos Therapeutics USD 1.19M 428K Sep/2025
Amgen USD 5.9B 773M Dec/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
Bayer EUR 10.33B 126M Dec/2025
Bristol-Myers Squibb USD 8.3B 10.25B Dec/2025
CSL USD 5.7B 2.82B Dec/2025
Curis USD -13.99M 7.38M Jun/2025
Eli Lilly USD 10.31B 1.09B Dec/2025
Exelixis USD 362.75M 21.35M Dec/2025
Gilead Sciences USD 4.96B 707M Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
Incyte USD 1.12B 3.53B Dec/2025
Merck USD 10.16B 558M Dec/2025
Novartis USD 9.86B 115M Sep/2025
Pfizer USD 12.91B 79.89B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 10.51B 1.21B Dec/2025
Takeda JPY 1.02T 400.98B Dec/2025
TG Therapeutics USD 142.08M 9.74M Dec/2025
Verastem USD 37.03M 8.97M Sep/2024
Xoma USD 22.84M 1.67M Sep/2024